Cargando…
Probing SH2-domains using Inhibitor Affinity Purification (IAP)
BACKGROUND: Many human diseases are correlated with the dysregulation of signal transduction processes. One of the most important protein interaction domains in the context of signal transduction is the Src homology 2 (SH2) domain that binds phosphotyrosine residues. Hence, appropriate methods for t...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110944/ https://www.ncbi.nlm.nih.gov/pubmed/25067910 http://dx.doi.org/10.1186/1477-5956-12-41 |
_version_ | 1782328042057629696 |
---|---|
author | Höfener, Michael Heinzlmeir, Stephanie Kuster, Bernhard Sewald, Norbert |
author_facet | Höfener, Michael Heinzlmeir, Stephanie Kuster, Bernhard Sewald, Norbert |
author_sort | Höfener, Michael |
collection | PubMed |
description | BACKGROUND: Many human diseases are correlated with the dysregulation of signal transduction processes. One of the most important protein interaction domains in the context of signal transduction is the Src homology 2 (SH2) domain that binds phosphotyrosine residues. Hence, appropriate methods for the investigation of SH2 proteins are indispensable in diagnostics and medicinal chemistry. Therefore, an affinity resin for the enrichment of all SH2 proteins in one experiment would be desirable. However, current methods are unable to address all SH2 proteins simultaneously with a single compound or a small array of compounds. RESULTS: In order to overcome these limitations for the investigation of this particular protein family in future experiments, a dipeptide-derived probe has been designed, synthesized and evaluated. This probe successfully enriched 22 SH2 proteins from mixed cell lysates which contained 50 SH2 proteins. Further characterization of the SH2 binding properties of the probe using depletion and competition experiments indicated its ability to enrich complexes consisting of SH2 domain bearing regulatory PI3K subunits and catalytic phosphoinositide 3-kinase (PI3K) subunits that have no SH2 domain. CONCLUSION: The results make this probe a promising starting point for the development of a mixed affinity resin with complete SH2 protein coverage. Moreover, the additional findings render it a valuable tool for the evaluation of PI3K complex interrupting inhibitors. |
format | Online Article Text |
id | pubmed-4110944 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-41109442014-07-26 Probing SH2-domains using Inhibitor Affinity Purification (IAP) Höfener, Michael Heinzlmeir, Stephanie Kuster, Bernhard Sewald, Norbert Proteome Sci Research BACKGROUND: Many human diseases are correlated with the dysregulation of signal transduction processes. One of the most important protein interaction domains in the context of signal transduction is the Src homology 2 (SH2) domain that binds phosphotyrosine residues. Hence, appropriate methods for the investigation of SH2 proteins are indispensable in diagnostics and medicinal chemistry. Therefore, an affinity resin for the enrichment of all SH2 proteins in one experiment would be desirable. However, current methods are unable to address all SH2 proteins simultaneously with a single compound or a small array of compounds. RESULTS: In order to overcome these limitations for the investigation of this particular protein family in future experiments, a dipeptide-derived probe has been designed, synthesized and evaluated. This probe successfully enriched 22 SH2 proteins from mixed cell lysates which contained 50 SH2 proteins. Further characterization of the SH2 binding properties of the probe using depletion and competition experiments indicated its ability to enrich complexes consisting of SH2 domain bearing regulatory PI3K subunits and catalytic phosphoinositide 3-kinase (PI3K) subunits that have no SH2 domain. CONCLUSION: The results make this probe a promising starting point for the development of a mixed affinity resin with complete SH2 protein coverage. Moreover, the additional findings render it a valuable tool for the evaluation of PI3K complex interrupting inhibitors. BioMed Central 2014-07-16 /pmc/articles/PMC4110944/ /pubmed/25067910 http://dx.doi.org/10.1186/1477-5956-12-41 Text en Copyright © 2014 Höfener et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Höfener, Michael Heinzlmeir, Stephanie Kuster, Bernhard Sewald, Norbert Probing SH2-domains using Inhibitor Affinity Purification (IAP) |
title | Probing SH2-domains using Inhibitor Affinity Purification (IAP) |
title_full | Probing SH2-domains using Inhibitor Affinity Purification (IAP) |
title_fullStr | Probing SH2-domains using Inhibitor Affinity Purification (IAP) |
title_full_unstemmed | Probing SH2-domains using Inhibitor Affinity Purification (IAP) |
title_short | Probing SH2-domains using Inhibitor Affinity Purification (IAP) |
title_sort | probing sh2-domains using inhibitor affinity purification (iap) |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110944/ https://www.ncbi.nlm.nih.gov/pubmed/25067910 http://dx.doi.org/10.1186/1477-5956-12-41 |
work_keys_str_mv | AT hofenermichael probingsh2domainsusinginhibitoraffinitypurificationiap AT heinzlmeirstephanie probingsh2domainsusinginhibitoraffinitypurificationiap AT kusterbernhard probingsh2domainsusinginhibitoraffinitypurificationiap AT sewaldnorbert probingsh2domainsusinginhibitoraffinitypurificationiap |